AP-2γ induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells

Neoplasia

Volumn 8, Issue 7, 2006, Pages 568-577

  Li, Hualei ^a   Goswami, Prabhat C ^a   Domann, Frederick E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

AP 2; Carcinoma; Cell cycle; p21; Tumor suppressor

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ADENOVIRUS VECTOR; CYCLIN D1; MESSENGER RNA; PROTEIN P21; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TRANSCRIPTION FACTOR AP 2GAMMA; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; BIOSYNTHESIS; CARCINOMA; CELL CYCLE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2; UP-REGULATION;

EID: 33745967216     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06367     Document Type: Article

References (44)

1. Mitchell PJ, Wang C, and Tjian R (1987). Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40T antigen. Cell 50, 847-861.
2. Williams T, Admon A, Luscher B, and Tjian R (1988). Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2, 1557-1569.
3. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F, Hofstadter F, Schule R, and Buettner R (1995). Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development 121, 2779-2788.
4. Chazaud C, Oulad-Abdelghani M, Bouillet P, Decimo D, Chambon P, and Dolle P (1996). AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 54, 83-94.
5. Zhao F, Satoda M, Licht JD, Hayashizaki Y, and Gelb BD (2001). Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 276, 40755-40760.
6. Tummala R, Romano R-A, Fuchs E, and Sinha S (2003). Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family. Gene 321, 93-102.
7. Williams T and Tjian R (1991). Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science 251, 1067-1071.
8. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, and Williams T (1996). Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381, 238-241.
9. Schorle H, Meier P, Buchert M, Jaenisch R, and Mitchell PJ (1996). Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235-238.
10. West-Mays JA, Zhang J, Nottoli T, Hagopian-Donaldson S, Libby D, Strissel KJ, and Williams T (1999). AP-2 alpha transcription factor is required for early morphogenesis of the lens vesicle. Dev Biol 206, 46-62.
11. Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, and Williams T (1998). AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. PNAS 95, 13714-13719.
12. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, and Williams T (2002). Transcription factor AP-2 gamma is essential in the extra-embryonic lineages for early postimplantation development. Development 129, 2733-2747.
13. Huang S, Jean D, Luca M, Tainsky MA, and Bar-Eli M (1998). Loss of AP-2 results in downregulation of c-kit and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17, 4358-4369.
14. Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, and Bar-Eli M (1998). Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem 273, 16501-16508.
15. Bar-Eli M (1999). Role of AP-2 in tumor growth and metastasis of human melanoma. Cancer Metastasis Rev 18, 377-385.
16. Marreiros A, Czolij R, Yardley G, Crossley M, and Jackson P (2003). Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53. Gene 302, 155-164.
17. Turner B, Zhang J, Gumbs A, Maher M, Kaplan L, Carter D, Glazer P, Hurst H, Haffty B, and Williams T (1998). Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 58, 5466-5472.
18. Zhu C-H and Domann FE (2002). Dominant negative interference of transcription factor AP-2 causes inhibition of REBB-3 expression and suppresses malignant cell growth. Breast Cancer Res Treat 71, 47-57.
19. McPherson L and Weigel R (1999). AP-2 alpha and AP-2 gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res 27, 4040-4049.
20. Wajapeyee N and Somasundaram K (2003). Cell cycle arrest and apoptosis induction by activator protein 2 alpha and the role of p53 and p21WAF1/CIP1 in AP-2 alpha-mediated growth inhibition. J Biol Chem 278, 52093-52101.
21. Nyormoi O, Wang Z, Doan D, Ruiz M, McConkey D, and Bar-Eli M (2001). Transcription factor AP-2{alpha} is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells. Mol Cell Biol 21, 4856-4867.
22. McPherson LA, Loktev AV, and Weigel RJ (2002). Tumor suppressor activity of AP-2 alpha mediated through a direct interaction with p53. J Biol Chem 277, 45028-45033.
23. Wu F and Lee A (1998). Identification of AP-2 as an interactive target of RB and a regulator of the G1/S control element of the hamster histone H3.2 promoter. Nucleic Acids Res 26, 4837-4845.
24. Batsche E, Muchardt C, Behrens J, Hurst HC, and Cremisi C (1998). Rb and c-myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 18, 3647-3658.
25. Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, and Bar-Eli M (2004). Activator protein 2 alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res 64, 631-638.
26. Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M, and Liu M (2006). Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2 alpha and specificity protein-1. J Biol Chem 281, 51-58.
27. Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietilainen T, Bohm J, Eskelinen M, and Kosma V-M (2002). Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Clin Cancer Res 8, 3487-3495.
28. Gee JMW, Robertson JFR, Ellis IO, Nicholson RI, and Hurst HC (2000). Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol 189, 514-520.
29. Douglas DB, Akiyama Y, Carraway H, Belinsky SA, Esteller M, Gabrielson E, Weitzman S, Williams T, Herman JG, and Baylin SB (2004). Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2 alpha expression during progression of breast cancer. Cancer Res 64, 1611-1620.
30. Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, Leffers H, and Meyts ER-D (2004). Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 10, 8521-8530.
31. Pauls K, Jager R, Weber S, Wardelmann E, Koch A, Buttner R, and Schorle H (2005). Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors. Int J Cancer 115, 470-477.
32. Jager R, Friedrichs N, Heim I, Buttner R, and Schorle H (2005). Dual role of AP-2 gamma in ERBB-2-induced mammary tumorigenesis. Breast Cancer Res Treat 90, 273-280.
33. Zeng YX, Somasundaram K, and el-Deiry WS (1997). AP-2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet 15, 78-82.
34. Zhu C-H, Huang Y, Oberley LW, and Domann FE (2001). A family of AP-2 proteins down-regulate manganese superoxide dismutase expression. J Biol Chem 276, 14407-14413.
35. Li H, Watts GS, Oshiro MM, Futscher BW, and Domann FE (2006). AP-2 alpha and AP-2 gamma are transcriptional targets of p53 in human breast carcinoma cells. Oncogene (in press). DOI: 10.1038/sj.onc.1209534.
36. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, and Sutherland RL (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127-2133.
37. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, and Bartek J (1994). Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57, 353-361.
38. Fu M, Wang C, Li Z, Sakamaki T, and Pestell RG (2004). Cyclin D1: normal and abnormal functions [minireview]. Endocrinology 145, 5439-5447.
39. Weinberg RA (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
40. Modugno M, Tagliabue E, Ardini E, Berno V, Galmozzi E, Bortoli MD, Castronovo V, and Menard S (2002). p53-dependent downregulation of metastasis-associated laminin receptor. Nature 21, 7478-7487.
41. Werling U and Schorle H (2002). Transcription factor gene AP-2-{gamma} essential for early murine development. Mol Cell Biol 22, 3149-3156.
42. Bar-Eli M (2001). Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res 14, 78-85.
43. Hilger-Eversheim K, Moser M, Schorle H, and Buettner R (2000). Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260, 1-12.
44. Paggi MG, Bonetto F, Severino A, Baldi A, Battista T, Bucci F, Felsani A, Lombardi D, and Giordano A (2001). The retinoblastoma-related RB2/p130 gene is an effector downstream of AP-2 during neural differentiation. Oncogene 20, 2570-2578.